Workshop Date and Time

Monday, December 7, 2020, 1:30 – 2:30 pm, Eastern Time Register Now

Registrants can listen in live over the phone or online as a webcast.

Topics Covered

  • Overview of Diagnostic Technologies and Biomarkers, in the Context of COVID-19
  • How These Technologies Improve Treatment Decisions
  • Why the Molecular Portrait of Cancer is Important
  • The Role of the Pathologist
  • Benefits of Diagnostic Technologies, Biomarkers and Precision Medicine
  • Predicting Response to Treatment
  • Clinical Trials: How Research Contributes to Your Treatment Options
  • Questions to Ask Your Health Care Team
  • The Increasing Role of Telehealth/Telemedicine Appointments
  • Guidelines to Prepare for Telehealth/Telemedicine Appointments
  • Quality-of-Life Concerns
  • Questions for Our Panel of Experts

Our Panel of Experts

Mark G. Kris, MD

William and Joy Ruane Chair in Thoracic Oncology, Attending Physician, Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College

Michael J. Mauro, MD

Leader, Myeloproliferative Neoplasms Program, Member, Memorial Sloan Kettering Cancer Center, Professor, Weill Cornell Medicine

Tanios Bekaii-Saab, MD, FACP

Leader, Gastrointestinal Cancer Program, Mayo Clinic Cancer Center, Professor, Mayo Clinic College of Medicine and Science, Consultant, Mayo Clinic in Arizona

Sarah E. Kerr, MD

Pathologist, Hospital Pathology Associates, P.A., Divisions of Cytopathology; Gynecologic and Perinatal Pathology; Molecular Diagnostic Lead Pathologist for Next Generation Sequencing Development and Practice; Allina Health Laboratory (A Part of Abbott Northwestern Hospital), Minneapolis, MN

Tara Burke, PhD

Senior Director of Public Policy and Advocacy, Association for Molecular Pathology (AMP)

Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW

Director of Education and Training, CancerCare

Continuing Education Credits

(Live Only)

Social Workers: This program has been submitted to the University of Texas MD Anderson Cancer Center, an approved provider through the Texas State Board of Social Work Examiners, provider #CS4607, for 1.0 Contact Hour.

CancerCare, Inc. is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0088. This workshop is approved for 1.0 Contact Hour.

Registered Dietitians: This program has been submitted to the Commission on Dietetic Registration for one Continuing Professional Education Unit (CPEU).

To request continuing education paperwork, please email your name, profession, and address to connect@cancercare.org after the program. All paperwork for continuing education credit must be requested, completed, and submitted within two weeks of the live program.

Brochure

You can download the brochure for this workshop(pdf)(80.9 KB)

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.